Different physical treatment modalities for lymphoedema developing after axillary lymph node dissection for breast cancer: A reviewDEVOOGDT, Nele; VAN KAMPEN, Marijke; GERAERTS, Inge et al.European journal of obstetrics, gynecology, and reproductive biology. 2010, Vol 149, Num 1, pp 3-9, issn 0301-2115, 7 p.Article

Lifestyle changes and breast cancer prognosis : a reviewKELLEN, Eliane; VANSANT, Greet; CHRISTIAENS, Marie-Rose et al.Breast cancer research and treatment. 2009, Vol 114, Num 1, pp 13-22, issn 0167-6806, 10 p.Article

Prospective assessment of the endometrium in postmenopausal breast cancer patients treated with fulvestrantMORALES, Leilani; NEVEN, Patrick; TIMMERMAN, Dirk et al.Breast cancer research and treatment. 2009, Vol 117, Num 1, pp 77-81, issn 0167-6806, 5 p.Article

Longitudinal Assessment of Chemotherapy-Induced Alterations in Brain Activation During Multitasking and Its Relation With Cognitive ComplaintsDEPREZ, Sabine; VANDENBULCKE, Mathieu; PEETERS, Ronald et al.Journal of clinical oncology. 2014, Vol 32, Num 19, pp 2031-2038, issn 0732-183X, 8 p.Article

Relationship Between Age and Axillary Lymph Node Involvement in Women With Breast CancerWILDIERS, Hans; VAN CALSTER, Ben; VAN HUFFEL, Sabine et al.Journal of clinical oncology. 2009, Vol 27, Num 18, pp 2931-2937, issn 0732-183X, 7 p.Article

Qualitative Assessment of the Progesterone Receptor and HER2 Improves the Nottingham Prognostic Index Up to 5 Years After Breast Cancer DiagnosisVAN BELLE, Vanya; VAN CALSTER, Ben; MOERMAN, Philippe et al.Journal of clinical oncology. 2010, Vol 28, Num 27, pp 4129-4134, issn 0732-183X, 6 p.Article

Short-term outcome of primary operated early breast cancer by hormone and HER-2 receptorsBROUCKAERT, Olivier; PINTENS, Saskia; DECOCK, Julie et al.Breast cancer research and treatment. 2009, Vol 115, Num 2, pp 349-358, issn 0167-6806, 10 p.Article

Polysomy 17 in Breast Cancer : Clinicopathologic Significance and Impact on HER-2 TestingVANDEN BEMPT, Isabelle; VAN LOO, Peter; DRIJKONINGEN, Maria et al.Journal of clinical oncology. 2008, Vol 26, Num 30, pp 4869-4874, issn 0732-183X, 6 p.Article

Longitudinal Assessment of Chemotherapy-Induced Structural Changes in Cerebral White Matter and Its Correlation With Impaired Cognitive FunctioningDEPREZ, Sabine; AMANT, Frederic; SUNAERT, Stefan et al.Journal of clinical oncology. 2012, Vol 30, Num 3, pp 274-281, issn 0732-183X, 8 p.Article

Chemotherapy-Induced Structural Changes in Cerebral White Matter and its Correlation With Impaired Cognitive Functioning in Breast Cancer PatientsDEPREZ, Sabine; AMANT, Frederic; VANDENBERGHE, Joris et al.Human brain mapping. 2011, Vol 32, Num 3, pp 480-493, issn 1065-9471, 14 p.Article

Physical activity levels after treatment for breast cancer: one-year follow-upDEVOOGDT, Nele; VAN KAMPEN, Marijke; GERAERTS, Inge et al.Breast cancer research and treatment. 2010, Vol 123, Num 2, pp 417-425, issn 0167-6806, 9 p.Article

Prospective Study to Assess Short-Term Intra-Articular and Tenosynovial Changes in the Aromatase Inhibitor-Associated Arthralgia SyndromeMORALES, Leilani; PANS, Steven; NEVEN, Patrick et al.Journal of clinical oncology. 2008, Vol 26, Num 19, pp 3147-3152, issn 0732-183X, 6 p.Article

Arthralgia induced by endocrine treatment for breast cancer: A prospective study of serum levels of insulin like growth factor-I, its binding protein and oestrogensLINTERMANS, Anneleen; VANDERSCHUEREN, Dirk; VERMEERSCH, Pieter et al.European journal of cancer (1990). 2014, Vol 50, Num 17, pp 2925-2931, issn 0959-8049, 7 p.Article

CHEK2^*1100delC Heterozygosity in Women With Breast Cancer Associated With Early Death, Breast Cancer―Specific Death, and Increased Risk of a Second Breast CancerWEISCHER, Maren; NORDESTGAARD, Børge G; DEVILEE, Peter et al.Journal of clinical oncology. 2012, Vol 30, Num 35, pp 4308-4316, issn 0732-183X, 9 p.Article

The E2F-regulated gene Chk1 is highly expressed in triple-negative estrogen receptor-/progesterone receptor-/HER-2-breast carcinomasVERLINDEN, Lieve; VANDEN BEMPT, Isabelle; VERSTUYF, Annemieke et al.Cancer research (Baltimore). 2007, Vol 67, Num 14, pp 6574-6581, issn 0008-5472, 8 p.Article

Vitamin D status at breast cancer diagnosis: correlation with tumor characteristics, disease outcome, and genetic determinants of vitamin D insufficiencyHATS, Sigrid; LAMBRECHTS, Diether; KRIEBITZSCH, Carsten et al.Carcinogenesis (New York. Print). 2012, Vol 33, Num 7, pp 1319-1326, issn 0143-3334, 8 p.Article

Axillary lymph node status of operable breast cancers by combined steroid receptor and HER-2 status : triple positive tumours are more likely lymph node positiveVAN CALSTER, Ben; VANDEN BEMPT, Isabelle; AMANT, Frederic et al.Breast cancer research and treatment. 2009, Vol 113, Num 1, pp 181-187, issn 0167-6806, 7 p.Article

Debilitating musculoskeletal pain and stiffness with letrozole and exemestane : associated tenosynovial changes on magnetic resonance imagingMORALES, Leilani; PANS, Steven; SMEETS, Ann et al.Breast cancer research and treatment. 2007, Vol 104, Num 1, pp 87-91, issn 0167-6806, 5 p.Article

Detection of micrometastatic disease and monitoring of perioperative tumor cell dissemination in primary operable breast cancer patients using real-time quantitative reverse transcription-PCRSAAD ISMAIL, Mohamed; WYNENDAELE, Wim; VANDEKERCKHOVE, Philippe et al.Clinical cancer research. 2004, Vol 10, Num 1, pp 196-201, issn 1078-0432, 6 p., 1Article

Association between HER-2/neu and the progesterone receptor in oestrogen-dependent breast cancer is age-relatedHUANG, Huei-Jean; NEVEN, Patrick; DRIJKONINGEN, Maria et al.Breast cancer research and treatment. 2005, Vol 91, Num 1, pp 81-87, issn 0167-6806, 7 p.Article

Fulvestrant (Faslodex™) in advanced breast cancer : clinical experience from a Belgian cooperative studyNEVEN, Patrick; PARIDAENS, Robert; FONTAINE, Christel et al.Breast cancer research and treatment. 2008, Vol 109, Num 1, pp 59-65, issn 0167-6806, 7 p.Article